To investigate whether bvPLA2 has the potential to ameliorate AD-like skin lesions through the induction of Tregs, we depleted Tregs using an anti-CD25 mAb (clone: PC61) and determined CD4+CD25+ populations in spleen on day 1 and 7. Here, CD4 is linked to Alzheimer disease.